Wu CL - Search Results

1

PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53.

Liu Q, Gheorghiu L, Drumm M, Clayman R, Eidelman A, Wszolek MF, Olumi A, Feldman A, Wang M, Marcar L, Citrin DE, Wu CL, Benes CH, Efstathiou JA, Willers H. Liu Q, et al. Among authors: wu cl. Oncogene. 2018 May;37(21):2793-2805. doi: 10.1038/s41388-018-0130-6. Epub 2018 Mar 7. Oncogene. 2018. PMID: 29511347 Free PMC article.

2

Stromally expressed c-Jun regulates proliferation of prostate epithelial cells.

Li W, Wu CL, Febbo PG, Olumi AF. Li W, et al. Among authors: wu cl. Am J Pathol. 2007 Oct;171(4):1189-98. doi: 10.2353/ajpath.2007.070285. Epub 2007 Aug 16. Am J Pathol. 2007. PMID: 17702894 Free PMC article.

3

Cystatin B as a tissue and urinary biomarker of bladder cancer recurrence and disease progression.

Feldman AS, Banyard J, Wu CL, McDougal WS, Zetter BR. Feldman AS, et al. Among authors: wu cl. Clin Cancer Res. 2009 Feb 1;15(3):1024-31. doi: 10.1158/1078-0432.CCR-08-1143. Clin Cancer Res. 2009. PMID: 19188175 Free PMC article.

4

Sensitive multiplexed analysis of kinase activities and activity-based kinase identification.

Kubota K, Anjum R, Yu Y, Kunz RC, Andersen JN, Kraus M, Keilhack H, Nagashima K, Krauss S, Paweletz C, Hendrickson RC, Feldman AS, Wu CL, Rush J, Villén J, Gygi SP. Kubota K, et al. Among authors: wu cl. Nat Biotechnol. 2009 Oct;27(10):933-40. doi: 10.1038/nbt.1566. Epub 2009 Oct 4. Nat Biotechnol. 2009. PMID: 19801977 Free PMC article.

5

Reduced levels of 5-α reductase 2 in adult prostate tissue and implications for BPH therapy.

Niu Y, Ge R, Hu L, Diaz C, Wang Z, Wu CL, Olumi AF. Niu Y, et al. Among authors: wu cl. Prostate. 2011 Sep;71(12):1317-24. doi: 10.1002/pros.21348. Epub 2011 Feb 9. Prostate. 2011. PMID: 21308715

6

Men with organ-confined prostate cancer and positive surgical margins develop biochemical failure at a similar rate to men with extracapsular extension.

Psutka SP, Feldman AS, Rodin D, Olumi AF, Wu CL, McDougal WS. Psutka SP, et al. Among authors: wu cl. Urology. 2011 Jul;78(1):121-5. doi: 10.1016/j.urology.2010.10.036. Epub 2011 Mar 16. Urology. 2011. PMID: 21411125

7

Smaller prostate gland size and older age predict Gleason score upgrading.

Gershman B, Dahl DM, Olumi AF, Young RH, McDougal WS, Wu CL. Gershman B, et al. Among authors: wu cl. Urol Oncol. 2013 Oct;31(7):1033-7. doi: 10.1016/j.urolonc.2011.11.032. Epub 2011 Dec 28. Urol Oncol. 2013. PMID: 22206627

8

A close surgical margin after radical prostatectomy is an independent predictor of recurrence.

Lu J, Wirth GJ, Wu S, Chen J, Dahl DM, Olumi AF, Young RH, McDougal WS, Wu CL. Lu J, et al. Among authors: wu s, wu cl. J Urol. 2012 Jul;188(1):91-7. doi: 10.1016/j.juro.2012.02.2565. Epub 2012 May 12. J Urol. 2012. PMID: 22578729

9

Impact on the clinical outcome of prostate cancer by the 2005 international society of urological pathology modified Gleason grading system.

Dong F, Wang C, Farris AB, Wu S, Lee H, Olumi AF, McDougal WS, Young RH, Wu CL. Dong F, et al. Among authors: wu s, wu cl. Am J Surg Pathol. 2012 Jun;36(6):838-43. doi: 10.1097/PAS.0b013e3182486faf. Am J Surg Pathol. 2012. PMID: 22592143

10

Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer.

Aizer AA, Paly JJ, Zietman AL, Nguyen PL, Beard CJ, Rao SK, Kaplan ID, Niemierko A, Hirsch MS, Wu CL, Olumi AF, Michaelson MD, D'Amico AV, Efstathiou JA. Aizer AA, et al. Among authors: wu cl. J Clin Oncol. 2012 Sep 1;30(25):3071-6. doi: 10.1200/JCO.2012.42.8466. Epub 2012 Jul 30. J Clin Oncol. 2012. PMID: 22851571

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,921 results

Search Page